Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ingredient as the company's ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients with chronic kidney disease and diabetes. Read more here.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

President Donald Trump issued executive orders late Friday reviving some of his first term’s anti-abortion policies, like ...

For the 18 th year running, Apple leads the list of the World's Most Admired Companies. The list, in its 27 th year, is created in partnership between Fortune and Korn Ferry (NYSE:KFY). The World's ...

Musk texted Tangen it would be too “difficult and expensive” to travel to Oslo for a home-cooked dinner with other CEOs.

G/O Media is once again attempting to use AI to churn out content — while simultaneously warning that anything the AI ...

Every year, 21.5 million people are forcibly displaced by floods, droughts, wildfires, and storms. This number ...

Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

I’m not going to report record revenue, but it was nonetheless a robust year," CEO Bernard Arnault said during the earnings ...